Philip A. DeSimone

807 total citations
16 papers, 618 citations indexed

About

Philip A. DeSimone is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Surgery. According to data from OpenAlex, Philip A. DeSimone has authored 16 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Public Health, Environmental and Occupational Health and 2 papers in Surgery. Recurrent topics in Philip A. DeSimone's work include Colorectal Cancer Treatments and Studies (3 papers), Cancer Treatment and Pharmacology (3 papers) and Cancer therapeutics and mechanisms (2 papers). Philip A. DeSimone is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), Cancer Treatment and Pharmacology (3 papers) and Cancer therapeutics and mechanisms (2 papers). Philip A. DeSimone collaborates with scholars based in United States and Poland. Philip A. DeSimone's co-authors include Ewa Marciniak, Merrill J. Egorin, Kenneth B. Ain, David W. Snyder, Lori Styles, Elliott Vichinsky, George A. Davis, Kenneth I. Ataga, Paul Swerdlow and Jonathan W. Stocker and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.

In The Last Decade

Philip A. DeSimone

16 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip A. DeSimone United States 7 185 165 161 118 109 16 618
V. Facchini Italy 14 64 0.3× 59 0.4× 224 1.4× 117 1.0× 91 0.8× 33 772
Павел Зак Czechia 15 64 0.3× 164 1.0× 90 0.6× 100 0.8× 69 0.6× 89 562
Joanna Sawicka United States 15 267 1.4× 57 0.3× 282 1.8× 135 1.1× 119 1.1× 23 899
Tusar Giri United States 16 38 0.2× 168 1.0× 55 0.3× 79 0.7× 35 0.3× 35 599
Grace Monori United Kingdom 8 51 0.3× 74 0.4× 75 0.5× 123 1.0× 39 0.4× 9 422
San‐Chi Chen Taiwan 16 64 0.3× 53 0.3× 260 1.6× 128 1.1× 118 1.1× 53 785
Tamás Magyarlaki Hungary 14 53 0.3× 67 0.4× 59 0.4× 111 0.9× 225 2.1× 45 709
Magdolna Nagy Netherlands 15 40 0.2× 278 1.7× 44 0.3× 128 1.1× 102 0.9× 49 701
Charles Mahler Belgium 13 786 4.2× 42 0.3× 65 0.4× 137 1.2× 374 3.4× 21 1.1k
Janelle Staton Australia 12 25 0.1× 193 1.2× 22 0.1× 181 1.5× 65 0.6× 15 570

Countries citing papers authored by Philip A. DeSimone

Since Specialization
Citations

This map shows the geographic impact of Philip A. DeSimone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip A. DeSimone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip A. DeSimone more than expected).

Fields of papers citing papers by Philip A. DeSimone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip A. DeSimone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip A. DeSimone. The network helps show where Philip A. DeSimone may publish in the future.

Co-authorship network of co-authors of Philip A. DeSimone

This figure shows the co-authorship network connecting the top 25 collaborators of Philip A. DeSimone. A scholar is included among the top collaborators of Philip A. DeSimone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip A. DeSimone. Philip A. DeSimone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hilal, Talal, Mari Nakazawa, Susanne M. Arnold, et al.. (2016). Utility of comprehensive genomic profiling (CGP) at an NCI-designated cancer center for identifying clinically relevant genomic alterations (CRGA) and implementing genomically directed therapy (GDT).. Journal of Clinical Oncology. 34(15_suppl). e18018–e18018. 1 indexed citations
2.
Loaiza‐Bonilla, Arturo, Edgar Ben‐Josef, Jeffrey A. Drebin, et al.. (2016). Neoadjuvant nab-paclitaxel and gemcitabine (AG) in borderline resectable (BR) or unresectable (UR) locally advanced pancreatic adenocarcinoma (LAPC) in patients ineligible for FOLFIRINOX.. Journal of Clinical Oncology. 34(4_suppl). 328–328. 3 indexed citations
3.
Hosein, Peter J., Lowell Anthony, Ching‐Wei D. Tzeng, et al.. (2015). Paclitaxel, carboplatin, and capecitabine (TCX) with and without radiation in locally advanced and metastatic distal esophageal and esophagogastric junction cancer: A single-center retrospective review.. Journal of Clinical Oncology. 33(3_suppl). 197–197. 1 indexed citations
4.
DeSimone, Philip A., et al.. (2015). Nightly dosing of regorafenib.. Journal of Clinical Oncology. 33(3_suppl). 549–549. 3 indexed citations
5.
Arnold, Susanne M., John J. Rinehart, Eleftheria Tsakalozou, et al.. (2010). A Phase I Study of 7- t -Butyldimethylsilyl-10-Hydroxycamptothecin in Adult Patients with Refractory or Metastatic Solid Malignancies. Clinical Cancer Research. 16(2). 673–680. 23 indexed citations
6.
Ataga, Kenneth I., Eugene P. Orringer, Lori Styles, et al.. (2006). Dose‐Escalation Study of ICA‐17043 in Patients with Sickle Cell Disease. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(11). 1557–1564. 50 indexed citations
7.
Ain, Kenneth B., et al.. (2000). Treatment of Anaplastic Thyroid Carcinoma with Paclitaxel: Phase 2 Trial Using Ninety-Six-hour Infusion. Thyroid. 10(7). 587–594. 224 indexed citations
8.
Blue, Amy V., et al.. (1996). Housestaff attitudes toward a problem-based clerkship. Medical Teacher. 18(2). 133–134. 2 indexed citations
9.
McCown, William & Philip A. DeSimone. (1993). Impulses, impulsivity, and impulsive behaviors: A historical review of a contemporary issue.. American Psychological Association eBooks. 3–22. 6 indexed citations
10.
Thompson, John S., Steven A. Haist, Philip A. DeSimone, Joseph Engelberg, & Eugene C. Rich. (1992). The Accelerated Internal Medicine Program at the University of Kentucky. Annals of Internal Medicine. 116(12_Part_2). 1084–1087. 6 indexed citations
11.
Rehm, Stanley R., et al.. (1991). A proposed mechanism for cardboard-induced iron-deficiency anemia. The American Journal of Medicine. 90(6). 768–769. 1 indexed citations
12.
DeSimone, Philip A., et al.. (1984). Phase II studies of mitoxantrone (dihydroxyanthracenedione) in the treatment of advanced colorectal carcinoma. American Journal of Clinical Oncology. 7(5). 517–522. 11 indexed citations
13.
DeSimone, Philip A., et al.. (1979). Effect of a forced diuresis on the distribution and excretion (via urine and bile) of 195mplatinum when given as 195mplatinum cis-dichlorodiammineplatinum(II).. PubMed. 63(6). 951–60. 20 indexed citations
14.
Bourne, David W. A., et al.. (1979). Pharmacokinetics of cis-Dichlorodiammine Platinum(II) in Rats Using an External Loop-Eigenfunction Expansion Technique. Journal of Pharmaceutical Sciences. 68(12). 1571–1572. 3 indexed citations
15.
DeSimone, Philip A. & David W. Snyder. (1978). Hypoglossal nerve palsy in infectious mononucleosis. Neurology. 28(8). 844–844. 33 indexed citations
16.
Marciniak, Ewa, et al.. (1974). Familial Thrombosis Due to Antithrombin III Deficiency. Blood. 43(2). 219–231. 231 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V. Facchini Breakdown of academic impact, for papers by Павел Зак Breakdown of academic impact, for papers by Joanna Sawicka Breakdown of academic impact, for papers by Tusar Giri Breakdown of academic impact, for papers by Grace Monori Breakdown of academic impact, for papers by San‐Chi Chen Breakdown of academic impact, for papers by Tamás Magyarlaki Breakdown of academic impact, for papers by Magdolna Nagy Breakdown of academic impact, for papers by Charles Mahler Breakdown of academic impact, for papers by Janelle Staton
Rankless by CCL
2026